Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SOFIVA GENOMICS CoROCO:6615 +2.20%68 Days Inventory is 50.00 as of Dec. 2025, which is 4% above its 10-year median of 48.13. GuruFocus rates ROCO:6615 with a GF Score™ of 68/100 and a GF Value™ of NT$30.93 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 179 Medical Diagnostics & Research companies, SOFIVA GENOMICS Co ranks better than 56.42% on this metric.
The historical rank and industry rank for SOFIVA GENOMICS Co's Days Inventory or its related term are showing as below:
ROCO:6615'
s Days Inventory Range Over the Past 10 Years
Min: 32.32 Med: 48.13 Max: 55.22
Current: 55.22
During the past 13 years, SOFIVA GENOMICS Co's highest Days Inventory was 55.22. The lowest was 32.32. And the median was 48.13.
ROCO:6615's Days Inventory is ranked better than 56.42% of 179
companies
in the Medical Diagnostics & Research industry
Industry Median: 65.04
vs ROCO:6615: 55.22
SOFIVA GENOMICS Co's Days Inventory
declined
from Dec. 2024 (58.42) to Dec. 2025 (50.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
SOFIVA GENOMICS Co's Inventory Turnover for the
three
months ended in Dec. 2025 was 1.83.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
SOFIVA GENOMICS Co's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.42.
SOFIVA GENOMICS Co (ROCO:6615) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
SOFIVA GENOMICS Co's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
SOFIVA GENOMICS Co's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
SOFIVA GENOMICS Co Days Inventory Related Terms
SOFIVA GENOMICS Co Days Inventory Historical Data
* Premium members only.
The historical data trend for SOFIVA GENOMICS Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6615 vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, SOFIVA GENOMICS Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SOFIVA GENOMICS Co Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, SOFIVA GENOMICS Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where SOFIVA GENOMICS Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SOFIVA GENOMICS Co (ROCO:6615) has a Days Inventory of 50.00 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on SOFIVA GENOMICS Co and its competitors. This is near median its historical median of 48.13. Over the past decade, SOFIVA GENOMICS Co's Days Inventory has ranged from 32.32 to 55.22. According to the industry distribution chart, SOFIVA GENOMICS Co ranks #78 out of 179 companies in the Medical Diagnostics & Research industry, placing it in the top 43.6%.
Is SOFIVA GENOMICS Co's Days Inventory too high?
SOFIVA GENOMICS Co's current Days Inventory of 50.00 is near median its 10-year median of 48.13. Over the past 10 years, this metric has ranged from a low of 32.32 to a high of 55.22. The Medical Diagnostics & Research industry median Days Inventory is 65.04. SOFIVA GENOMICS Co's value of 50.00 is 23.1% below this industry median. Based on the distribution chart, SOFIVA GENOMICS Co ranks #78 out of 179 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, SOFIVA GENOMICS Co has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SOFIVA GENOMICS Co's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, SOFIVA GENOMICS Co ranks #78 out of 179 companies for Days Inventory. This puts SOFIVA GENOMICS Co in the upper half of its industry. The industry median Days Inventory is 65.04. SOFIVA GENOMICS Co's value of 50.00 is 23.1% below this benchmark. Historically, SOFIVA GENOMICS Co's own Days Inventory has ranged from 32.32 to 55.22 over the past decade. While the company's 10-year median is 48.13 vs. the industry median of 65.04, SOFIVA GENOMICS Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 65.04, based on 179 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SOFIVA GENOMICS Co's current Days Inventory of 50.00 is 23.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on SOFIVA GENOMICS Co and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 65.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SOFIVA GENOMICS Co's current Days Inventory is 50.00, which is near median its own 10-year median of 48.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOFIVA GENOMICS Co stock overvalued right now?
Based on GuruFocus' analysis, SOFIVA GENOMICS Co (ROCO:6615) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$30.93, compared to a current price of NT$34.90 — trading 12.8% above its estimated fair value. The current Days Inventory is 50.00, which is near median its 10-year median of 48.13 and 23.1% below the Medical Diagnostics & Research industry median of 65.04. SOFIVA GENOMICS Co's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For SOFIVA GENOMICS Co (ROCO:6615), the current Days Inventory is 50.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SOFIVA GENOMICS Co (ROCO:6615) Overvalued in 2026?
Based on GuruFocus' analysis, SOFIVA GENOMICS Co stock appears to be overvalued.
The current stock price of NT$34.90 is trading 12.8% above its estimated GF Value™ of NT$30.93.
GuruFocus considers SOFIVA GENOMICS Co to be Modestly Overvalued.
Key valuation signals for ROCO:6615:
Days Inventory: 50.00 (near median its 10-year median of 48.13)
GF Value™: NT$30.93 vs. price of NT$34.90 (12.8% above fair value)
Industry Position: 23.1% below the Medical Diagnostics & Research median (#78 of 179)
No single metric tells the full story. See the ROCO:6615 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SOFIVA GENOMICS Co Ltd provides medical diagnostic services. The services offered by the company include Prenatal, Reproductive, Cancer, Precision Medicine, Newborn, and Rare Diseases. Its testing categories include Genetic, Biochemical, and Chromosome. The business items of Sofiva Group are pre-pregnancy, prenatal, and neonatal genetic testing and medical testing, and other service income. Geographically, it generates the vast majority of its revenue from Taiwan.
68GF Score
Get the complete analysis for ROCO:6615
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6615 has been successfully added to your 
